By Christy Santhosh April 27 (Reuters) - Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax ...
Lilly will buy Ajax, whose lead medicine is a once-daily pill in the early stages of study for a rare type of blood cancer.
By Sriparna Roy April 24 (Reuters) - Eli Lilly's newly launched weight-loss pill had a modest second week, analysts said on ...
Eli Lilly shares slid nearly 4% Friday after early data on prescription volume for its new weight loss pill signaled it’s off ...
Eli Lilly continued its recent buying spree, agreeing to pay up to $2.3 billion for Ajax Therapeutics in a deal that bolsters ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results